JP2010537641A5 - - Google Patents

Download PDF

Info

Publication number
JP2010537641A5
JP2010537641A5 JP2010523124A JP2010523124A JP2010537641A5 JP 2010537641 A5 JP2010537641 A5 JP 2010537641A5 JP 2010523124 A JP2010523124 A JP 2010523124A JP 2010523124 A JP2010523124 A JP 2010523124A JP 2010537641 A5 JP2010537641 A5 JP 2010537641A5
Authority
JP
Japan
Prior art keywords
virus
cell
liquid
viral antigen
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010537641A (ja
JP5535910B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/074559 external-priority patent/WO2009029695A1/en
Publication of JP2010537641A publication Critical patent/JP2010537641A/ja
Publication of JP2010537641A5 publication Critical patent/JP2010537641A5/ja
Application granted granted Critical
Publication of JP5535910B2 publication Critical patent/JP5535910B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523124A 2007-08-28 2008-08-28 ウイルスワクチンを生産する方法 Active JP5535910B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96672407P 2007-08-28 2007-08-28
US60/966,724 2007-08-28
PCT/US2008/074559 WO2009029695A1 (en) 2007-08-28 2008-08-28 Method for producing viral vaccines

Publications (3)

Publication Number Publication Date
JP2010537641A JP2010537641A (ja) 2010-12-09
JP2010537641A5 true JP2010537641A5 (https=) 2011-10-20
JP5535910B2 JP5535910B2 (ja) 2014-07-02

Family

ID=39947984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523124A Active JP5535910B2 (ja) 2007-08-28 2008-08-28 ウイルスワクチンを生産する方法

Country Status (16)

Country Link
US (2) US8497112B2 (https=)
EP (1) EP2192917B1 (https=)
JP (1) JP5535910B2 (https=)
KR (1) KR101760844B1 (https=)
CN (1) CN101790381B (https=)
AU (1) AU2008293513B2 (https=)
BR (1) BRPI0816130A2 (https=)
CA (1) CA2696090C (https=)
ES (1) ES2459166T3 (https=)
HR (1) HRP20140375T1 (https=)
IL (1) IL203869A (https=)
PL (1) PL2192917T3 (https=)
RU (1) RU2496519C2 (https=)
SG (1) SG10201404101RA (https=)
SI (1) SI2192917T1 (https=)
WO (1) WO2009029695A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
WO2007052061A2 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines
EA201070066A1 (ru) * 2007-06-27 2010-06-30 Новартис Аг Вакцины против гриппа с низким содержанием добавок
WO2010092479A2 (en) 2009-02-10 2010-08-19 Novartis Ag Influenza vaccines with reduced amounts of squalene
AU2010270722B2 (en) 2009-07-06 2015-06-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process
US20130039943A1 (en) * 2010-05-03 2013-02-14 Bruno Rene Andre Novel method
MX342138B (es) 2010-07-06 2016-09-14 Variation Biotechnologies Inc Composiciones y metodos para el tratamiento de influenza.
CA2862864C (en) 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2862871C (en) 2011-01-13 2020-09-22 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
CA2841604C (en) * 2011-07-20 2020-01-21 Abbott Biologicals B.V. Process for producing viral antigen and vaccines
ES2726975T3 (es) * 2011-07-27 2019-10-11 Flash Therapeutics Método para la producción de partículas retrovíricas útiles para transducir células eucariotas
US20140328876A1 (en) 2011-11-18 2014-11-06 Variation Biotechnologies Inc. Synthetic derivatives of mpl and uses thereof
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
US20150079077A1 (en) 2012-01-27 2015-03-19 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
WO2015059065A1 (en) * 2013-10-22 2015-04-30 Roche Diagnostics Gmbh Methods for measuring cell-free virus particles from dried blood spots
FR3025107B1 (fr) * 2014-08-29 2018-10-05 Calixar Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
CN111979120B (zh) * 2019-05-23 2022-09-27 比欧联科供应链管理(北京)有限公司 一种狂犬疫苗核酸消化去除装置及实验方法
RU2754398C1 (ru) * 2020-06-25 2021-09-01 Общество с ограниченной ответственностью «ФОРТ» Способ получения четырехвалентной вакцины для профилактики гриппа

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH589453A5 (https=) * 1974-01-14 1977-07-15 Sandoz Ag
FR2475572A1 (fr) 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
FR2533548B1 (fr) * 1982-09-28 1985-07-26 Degremont Procede et appareil de traitement anaerobie d'eaux residuaires dans un filtre a remplissage de materiau granulaire
EP0172433A3 (en) * 1984-08-02 1989-04-05 Tektronix, Inc. Display method and apparatus employing cursor panning
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
RU2082433C1 (ru) * 1992-07-13 1997-06-27 Николай Владимирович Костючек Способ вакцинопрофилактики гриппа
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
CN1223589A (zh) * 1996-05-06 1999-07-21 美国拜尔公司 包含鹦鹉热衣原体的猫疫苗及其制备方法
AT405939B (de) * 1997-02-24 1999-12-27 Immuno Ag Verfahren zur inaktivierung von lipidumhüllten viren
US6841374B1 (en) * 1998-10-05 2005-01-11 Research Foundation For Microbial Diseases Of Osaka University Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same
CA2355270A1 (en) 1998-12-17 2000-06-22 Aventis Pasteur Limited Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
US7521220B2 (en) * 1999-11-26 2009-04-21 Crucell Holland B.V. Production of vaccines
KR20030046395A (ko) 2000-07-28 2003-06-12 인스파이어 파마슈티컬스 인코퍼레이티드 인돌 유도체를 사용하여 안압을 감소시키는 방법
GB0024089D0 (en) * 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
TWI228420B (en) * 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
RU2195959C1 (ru) * 2001-11-02 2003-01-10 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Инактивированная вакцина против синдрома гидроперикардита кур
RU2261111C1 (ru) * 2004-04-08 2005-09-27 Сергеев Виталий Александрович Инактивированная вакцина против вирусных пневмогастроэнтеритов крупного рогатого скота и телят и способ профилактики вирусных пневмогастроэнтеритов
US8703467B2 (en) * 2004-05-27 2014-04-22 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and UV light
CN1647822A (zh) * 2005-02-06 2005-08-03 北京生物制品研究所 脊髓灰质炎灭活疫苗及其制备方法
EP1724338A1 (en) * 2005-05-19 2006-11-22 Crucell Holland B.V. Methods for the production of a whole-inactivated West Nile Virus vaccine

Similar Documents

Publication Publication Date Title
JP2010537641A5 (https=)
RU2010111747A (ru) Способ получения противовирусных вакцин
KR101548790B1 (ko) 백신 제조를 위한 고역가 폴리오바이러스의 제조
JP2009034115A5 (https=)
JP2012025784A5 (https=)
JP2013515473A5 (https=)
JP5980947B2 (ja) 高感染価のパルボウイルスの生産方法
TW201311896A (zh) 製備病毒抗原及疫苗之方法
JP2009225809A5 (https=)
WO2015059714A1 (en) Emergency mode in a hybrid vehicle
DK3010537T3 (en) PROCEDURE FOR PREVENTING AGGREGATION OF VIRUS COMPONENTS
EA010057B1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
CN102599057A (zh) 采用病毒唑脱除马铃薯病毒的方法
CN102796708A (zh) 一种增殖甲型流感病毒的方法
TWI747866B (zh) 藉由去脂質化使病原體不活化
CN102614508B (zh) 一种人用流感病毒裂解疫苗的病毒裂解灭活方法
CN105396128A (zh) 一种纯化脊髓灰质炎病毒液的方法
US8426124B2 (en) Two-step temperature profile for the propagation of viruses
CN102657857B (zh) 一种利用沙鼠肾细胞制备肠道病毒疫苗的方法
CN1843507B (zh) 一种人用腮腺炎病毒组份疫苗及其制备方法和应用
Hsu Cell fusion induced by a plant virus
US20240229007A1 (en) Inactivated vaccines & nucleic acid aptamer therapeutics derived therefrom
WO2018012498A1 (ja) リアソータントインフルエンザウイルス作出方法
CN120192936A (zh) 一种高剂量流感病毒裂解疫苗原液的制备方法
HK1223845B (en) Methods for the prevention of aggregation of viral components